Login / Signup

ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer.

Emma L O'DowdIlona TietzovaEmily BartlettAnand DevarajJürgen BiedererMarco BrambillaAlessandro BrunelliJoanna Chorostowska-WynimkoHerbert DecaluwéDirk DeruysscherWalter De WeverMatthew DonoghueAurelie FabreMina GagaWouter H Van GeffenGeorgia HardavellaHans-Ulrich KauczorAnna Kerpel-FroniusJan P van MeerbeeckBlin NagavciUrsula NestleNuria NovoaHelmut ProschMathias ProkopPaul Martin PutoraJanette RawlinsonMarie-Pierre RevelAnnemiek SnoeckxGiulia VeronesiRozemarijn VliegenthartSabine WeckbachTorsten G BlumDavid R Baldwin
Published in: The European respiratory journal (2023)
This European collaborative group has produced an incidental findings statement that can be followed during lung cancer screening. It will ensure that an evidence-based approach is used for reporting and managing incidental findings, which will mean that harms are minimised and any programme is as cost-effective as possible.
Keyphrases
  • low dose
  • computed tomography
  • study protocol
  • magnetic resonance imaging
  • quality improvement
  • estrogen receptor
  • randomized controlled trial
  • clinical trial
  • adverse drug
  • pet ct